Probiotic Supplement Testing Guide: CFU Claims, Viable Count & Shelf-Life Validation
The testing compliance core for probiotic supplements is CFU claim substantiation and viable count at end of shelf life. This guide covers CFU counting method selection, stability protocol design, strain identification requirements, and NSF/ANSI 455-2 and FDA compliance standards.
Probiotic CFU claims must be substantiated by end-of-shelf-life (EOS) viable counts, not manufacturing-time counts. Accelerated stability studies must cover realistic storage and shipping conditions, using strain-specific counting methods (e.g., MRS agar for lactobacilli).
The most common probiotic compliance mistakes
Many factories base CFU label claims on the viable count at manufacturing date, not the expected count at end of shelf life. FDA and NSF/ANSI 455-2 require CFU claims to be scientifically substantiated and valid throughout the shelf life. If the label states "1 billion CFU per capsule," you must demonstrate consumers opening the product on the last day of best-by date still receive at least 1 billion viable organisms.
- Basing claims on manufacturing-date counts instead of end-of-shelf-life counts
- Not validating temperature effects on viable counts during storage/shipping
- Using generic counting methods not optimized for specific strains
- Incomplete strain identification records (16S rRNA or equivalent)
Stability protocol design essentials
Probiotic stability testing must simulate real supply chain conditions across manufacturing, warehousing, transportation, and consumer use temperature/humidity ranges. Accelerated and real-time testing must run simultaneously, and thermal sensitivity differences between strains must be addressed in protocol design.
- Real-time conditions (25°C/60% RH or cold chain 4°C) covering full shelf life
- Accelerated conditions (40°C/75% RH) with at least 6 months of data
- Strain-specific selective media and counting methods per organism
How QTC supports probiotic compliance
QTC can help probiotic brands and factories evaluate existing stability protocol completeness, review COAs and specifications, identify potential issues in NSF or FDA audits, and coordinate third-party labs for viable counts and strain identification.
- CFU claim and stability protocol compliance review
- Strain identification and viable count COA document review
- Third-party lab coordination and test scope confirmation
FAQ
Are probiotic products required to declare CFU counts?+
US regulations (21 CFR) do not mandate CFU declarations, but if a label states a CFU count, that claim must be substantiated. However, many platforms (Amazon, iHerb) and retail buyers effectively require viable count results in COAs.
Must probiotics be cold-chain shipped?+
Not necessarily — it depends on the strain and formulation. Some spore-forming strains are stable at ambient temperatures; temperature-sensitive strains like Bifidobacterium typically require cold chain. The key is that stability data must support the storage conditions and shelf life stated on the label.
Next steps
If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.
